Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1985 Jan;53(1):1–4. doi: 10.1136/hrt.53.1.1

Management of primary pulmonary hypertension.

C M Oakley
PMCID: PMC481712  PMID: 3966945

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Mackworth-Young C. G., Boey M. L., Hull R. G., Saunders A., Gharavi A. E., Hughes G. R. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1024–1025. doi: 10.1136/bmj.287.6398.1024-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bourdillon P. D., Oakley C. M. Regression of primary pulmonary hypertension. Br Heart J. 1976 Mar;38(3):264–270. doi: 10.1136/hrt.38.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Camerini F., Alberti E., Klugmann S., Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J. 1980 Sep;44(3):352–356. doi: 10.1136/hrt.44.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen M. L., Kronzon I. Adverse hemodynamic effects of phentolamine in primary pulmonary hypertension. Ann Intern Med. 1981 Nov;95(5):591–592. doi: 10.7326/0003-4819-95-5-591. [DOI] [PubMed] [Google Scholar]
  5. Crevey B. J., Dantzker D. R., Bower J. S., Popat K. D., Walker S. D. Hemodynamic and gas exchange effects of intravenous diltiazem in patients with pulmonary hypertension. Am J Cardiol. 1982 Feb 18;49(3):578–583. doi: 10.1016/s0002-9149(82)80015-5. [DOI] [PubMed] [Google Scholar]
  6. Daoud F. S., Reeves J. T., Kelly D. B. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol. 1978 Nov;42(5):817–822. doi: 10.1016/0002-9149(78)90102-9. [DOI] [PubMed] [Google Scholar]
  7. Douglas J. G., Munro J. F., Kitchin A. H., Muir A. L., Proudfoot A. T. Pulmonary hypertension and fenfluramine. Br Med J (Clin Res Ed) 1981 Oct 3;283(6296):881–883. doi: 10.1136/bmj.283.6296.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Elkayam U. Vasodilator therapy in primary pulmonary hypertension. Chest. 1981 Mar;79(3):253–254. doi: 10.1378/chest.79.3.253. [DOI] [PubMed] [Google Scholar]
  9. FARRAR J. F., REYE R. D., STUCKEY D. Primary pulmonary hypertension in childhood. Br Heart J. 1961 Nov;23:605–615. doi: 10.1136/hrt.23.6.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fishman A. P. Primary pulmonary hypertension: more light or more tunnel? Ann Intern Med. 1981 Jun;94(6):815–817. doi: 10.7326/0003-4819-94-6-815. [DOI] [PubMed] [Google Scholar]
  11. Fujii A., Rabinovitch M., Matthews E. C. A case of spontaneous resolution of idiopathic pulmonary hypertension. Br Heart J. 1981 Nov;46(5):574–577. doi: 10.1136/hrt.46.5.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GARDNER D. L., DUTHIE J. J., MACLEOD J., ALLAN W. S. Pulmonary hypertension in rheumatoid arthritis: report of a case with intimal sclerosis of the pulmonary and digital arteries. Scott Med J. 1957 May;2(5):183–188. doi: 10.1177/003693305700200502. [DOI] [PubMed] [Google Scholar]
  13. Haworth S. G. Primary pulmonary hypertension. Br Heart J. 1983 Jun;49(6):517–521. doi: 10.1136/hrt.49.6.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hermiller J. B., Bambach D., Thompson M. J., Huss P., Fontana M. E., Magorien R. D., Unverferth D. V., Leier C. V. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Intern Med. 1982 Oct;97(4):480–489. doi: 10.7326/0003-4819-97-4-480. [DOI] [PubMed] [Google Scholar]
  15. Honey M., Cotter L., Davies N., Denison D. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax. 1980 Apr;35(4):269–276. doi: 10.1136/thx.35.4.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ikram H., Maslowski A. H., Nicholls M. G., Espiner E. A., Hull F. T. Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension. Br Heart J. 1982 Dec;48(6):541–545. doi: 10.1136/hrt.48.6.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Irey N. S., Norris H. J. Intimal vascular lesions associated with female reproductive steroids. Arch Pathol. 1973 Oct;96(4):227–234. [PubMed] [Google Scholar]
  18. Kambara H., Fujimoto K., Wakabayashi A., Kawai C. Primary pulmonary hypertension: beneficial therapy with diltiazem. Am Heart J. 1981 Feb;101(2):230–231. doi: 10.1016/0002-8703(81)90672-4. [DOI] [PubMed] [Google Scholar]
  19. Kanemoto N., Sasamoto H. [Hemodynamic changes in primary pulmonary hypertension. With special reference to prognosis (author's transl)]. Kokyu To Junkan. 1977 Nov;25(11):1017–1021. [PubMed] [Google Scholar]
  20. Kay J. M., Smith P., Heath D. Aminorex and the pulmonary circulation. Thorax. 1971 May;26(3):262–270. doi: 10.1136/thx.26.3.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kleiger R. E., Boxer M., Ingham R. E., Harrison D. C. Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest. 1976 Feb;69(2):143–147. doi: 10.1378/chest.69.2.143. [DOI] [PubMed] [Google Scholar]
  22. Klinke W. P., Gilbert J. A. Diazoxide in primary pulmonary hypertension. N Engl J Med. 1980 Jan 10;302(2):91–92. doi: 10.1056/NEJM198001103020204. [DOI] [PubMed] [Google Scholar]
  23. Kokubu T., Kazatani Y., Hamada M., Matsuzaki K., Ito T., Nishimura K., Ochi T., Daimon F., Joh T. Is captopril effective in primary pulmonary hypertension? Jpn Circ J. 1982 Oct;46(10):1095–1097. doi: 10.1253/jcj.46.1095. [DOI] [PubMed] [Google Scholar]
  24. Kronzon I., Cohen M., Winer H. E. Adverse effect of hydralazine in patients with primary pulmonary hypertension. JAMA. 1982 Jun 11;247(22):3112–3114. [PubMed] [Google Scholar]
  25. Lupi-Herrera E., Sandoval J., Seoane M., Bialostozky D. The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause. Circulation. 1982 Apr;65(4):645–650. doi: 10.1161/01.cir.65.4.645. [DOI] [PubMed] [Google Scholar]
  26. MELMON K. L., BRAUNWALD E. FAMILIAL PULMONARY HYPERTENSION. N Engl J Med. 1963 Oct 10;269:770–775. doi: 10.1056/NEJM196310102691502. [DOI] [PubMed] [Google Scholar]
  27. Meyrick B., Reid L. Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. Am J Pathol. 1979 Jan;94(1):37–50. [PMC free article] [PubMed] [Google Scholar]
  28. Moore P. F., Constantine J. W., Barth W. E. Pirbuterol, a selecttve beta2 adrenergic bronchodilator. J Pharmacol Exp Ther. 1978 Nov;207(2):410–418. [PubMed] [Google Scholar]
  29. Nagasaka Y., Akutsu H., Lee Y. S., Fujimoto S., Chikamori J. Longterm favorable effect of oxygen administration on a patient with primary pulmonary hypertension. Chest. 1978 Sep;74(3):299–300. doi: 10.1378/chest.74.3.299. [DOI] [PubMed] [Google Scholar]
  30. Oakley C., Somerville J. Oral contraceptives and progressive pulmonary vascular disease. Lancet. 1968 Apr 27;1(7548):890–893. doi: 10.1016/s0140-6736(68)90240-7. [DOI] [PubMed] [Google Scholar]
  31. Olukotun A. Y. Vasodilator therapy for pulmonary hypertension. N Engl J Med. 1980 May 29;302(22):1261–1262. [PubMed] [Google Scholar]
  32. Packer M., Greenberg B., Massie B., Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med. 1982 Jun 3;306(22):1326–1331. doi: 10.1056/NEJM198206033062203. [DOI] [PubMed] [Google Scholar]
  33. Pietro D. A., LaBresh K. A., Shulman R. M., Folland E. D., Parisi A. F., Sasahara A. A. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol. N Engl J Med. 1984 Apr 19;310(16):1032–1034. doi: 10.1056/NEJM198404193101606. [DOI] [PubMed] [Google Scholar]
  34. Rozkovec A., Bernstein R., Asherson R. A., Oakley C. M. Vascular reactivity and pulmonary hypertension in systemic sclerosis. Arthritis Rheum. 1983 Aug;26(8):1037–1040. doi: 10.1002/art.1780260815. [DOI] [PubMed] [Google Scholar]
  35. Rubin L. J., Peter R. H. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med. 1980 Jan 10;302(2):69–73. doi: 10.1056/NEJM198001103020201. [DOI] [PubMed] [Google Scholar]
  36. Rubino J. M., Schroeder J. S. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J. 1979 Sep;42(3):362–363. doi: 10.1136/hrt.42.3.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ruskin J. N., Hutter A. M., Jr Primary pulmonary hypertension treated with oral phentolamine. Ann Intern Med. 1979 May;90(5):772–774. doi: 10.7326/0003-4819-90-5-772. [DOI] [PubMed] [Google Scholar]
  38. SAMET P., BERNSTEIN W. H. LOSS OF REACTIVITY OF THE PULMONARY VASCULAR BED IN PRIMARY PULMONARY HYPERTENSION. Am Heart J. 1963 Aug;66:197–199. doi: 10.1016/0002-8703(63)90034-6. [DOI] [PubMed] [Google Scholar]
  39. Se Do Cha, Kirschbaum M., Maranhao V., Paine E., Gooch A. S. Phentolamine for primary pulmonary hypertension. Ann Intern Med. 1979 Dec;91(6):927–928. doi: 10.7326/0003-4819-91-6-927_2. [DOI] [PubMed] [Google Scholar]
  40. Shettigar U. R., Hultgren H. N., Specter M., Martin R., Davies D. H. Primary pulmonary hypertension favorable effect of isoproterenol. N Engl J Med. 1976 Dec 16;295(25):1414–1415. doi: 10.1056/NEJM197612162952506. [DOI] [PubMed] [Google Scholar]
  41. Suarez L. D., Sciandro E. E., Llera J. J., Perosio A. M. Long-term follow-up in primary pulmonary hypertension. Br Heart J. 1979 Jun;41(6):702–708. doi: 10.1136/hrt.41.6.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. VOGEL J. H., WEAVER W. F., ROSE R. L., BLOUNT S. G., Jr, GROVER R. F. Pulmonary hypertension on exertion in normal man living at 10,150 feet (Leadville, Colorado). Med Thorac. 1962;19:461–477. doi: 10.1159/000192254. [DOI] [PubMed] [Google Scholar]
  43. WADE G., BALL J. Unexplained pulmonary hypertension. Q J Med. 1957 Jan;26(101):83–119. [PubMed] [Google Scholar]
  44. WOOD P. Congenital heart disease; a review of its clinical aspects in the light of experience gained by means of modern techniques. II. Br Med J. 1950 Sep 23;2(4681):693–698. doi: 10.1136/bmj.2.4681.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. WOOD P. Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J. 1958 Oct;20(4):557–570. doi: 10.1136/hrt.20.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. WOOD P. Pulmonary hypertension. Br Med Bull. 1952;8(4):348–353. doi: 10.1093/oxfordjournals.bmb.a074201. [DOI] [PubMed] [Google Scholar]
  47. Wang S. W., Pohl J. E., Rowlands D. J., Wade E. G. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J. 1978 May;40(5):572–574. doi: 10.1136/hrt.40.5.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wise J. R., Jr Nifedipine in the treatment of primary pulmonary hypertension. Am Heart J. 1983 Apr;105(4):693–694. doi: 10.1016/0002-8703(83)90500-8. [DOI] [PubMed] [Google Scholar]
  49. Wood B. A., Tortoledo F., Luck J. C., Fennell W. H. Rapid attenuation of response to nifedipine in primary pulmonary hypertension. Chest. 1982 Dec;82(6):793–794. doi: 10.1378/chest.82.6.793. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES